BioLamina Inc

The role of laminin α5 in extracellular matrix organization during human chondrogenesis

Maintaining stable transgene expression during stem cell differentiation

Developing tissue-specific extracellular matrices for regenerative medicine

BioLamina and Axion BioSystems partner to advance organoid research for disease modeling and therapeutic discovery

Supporting large-scale drug discovery with patient-derived motor neurons

BioLamina appoints Sofia Helgesson as Chief Financial Officer